Nova Patents
AT250028T

Peptide derivatives as antithrombotic agents

Abstract

The invention involves a Thrombin inhibitor compound, its general formula (I) X-Y-NH-(CH2) r-G, x, y, r, and g has the meaning defined in the specification, involved and pharmaceutical formulations containing such compounds as thrombin inhibitors, inhibitors of blood coagulation and thrombo-embolism agents of disorder.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

51 members in 29 offices

This recordMember, by publication datePriority claim19 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
20655394United States of AmericaA

Members51

Family members, oldest first
DocumentOfficeKind
IL112795D0IsraelD0
CA2183464A1CanadaA1
WO9523609A1World Intellectual Property Organization (WIPO)A1
AU1975295AAustraliaA
EP0672658A1European Patent Office (EPO)A1
FI963451AFinlandA
NO963684D0NorwayD0
PE41696A1PeruA1
NO963684LNorwayL
HU9602408D0HungaryD0
ZA951617BSouth AfricaB
MX9603831AMexicoA
CN1147205AChinaA
KR970701693ARepublic of KoreaA
CZ258496A3CzechiaA3
HUT76330AHungaryA
JPH09509937AJapanA
PL320637A1PolandA1
BR9506979ABrazilA
NZ282588ANew ZealandA
US5705487AUnited States of AmericaA
AU684918B2AustraliaB2
US5707966AUnited States of AmericaA
US5710130AUnited States of AmericaA
US5726159AUnited States of AmericaA
US5914319AUnited States of AmericaA
RU2148585C1Russian FederationC1
TW401403BTaiwan Province of ChinaB
NO309034B1NorwayB1
IL112795AIsraelA
PL181306B1PolandB1
KR100337271B1Republic of KoreaB1
AU684918CAustraliaC
EP0672658B1European Patent Office (EPO)B1
AT250028TThis recordAustriaT
ATE250028T1AustriaT1
DE69531753D1GermanyD1
EP1361212A1European Patent Office (EPO)A1
DK0672658T3DenmarkT3
CN1134264CChinaC
PT672658EPortugalE
SI0672658T1SloveniaT1
ES2206479T3SpainT3
UA67715C2UkraineC2
CN1515550AChinaA
DE69531753T2GermanyT2
CZ294674B6CzechiaB6
MY119987AMalaysiaA
JP4081138B2JapanB2
CN100491348CChinaC
HU227356B1HungaryB1